Geneos Wealth Management’s T. Rowe Price TROW Stock Holding History

Geneos Wealth Management’s Portfolio TROW Stock Details TROW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$85.2K	Buy	945 +339	+56%	+$32.8K	﹤0.01%	1225
2025 Q4	$62K	Sell	606 -637	-51%	-$65.7K	﹤0.01%	1311
2025 Q3	$128K	Buy	1,243 +62	+5%	+$6.52K	﹤0.01%	1041
2025 Q2	$114K	Sell	1,181 -755	-39%	-$69.3K	﹤0.01%	1201
2025 Q1	$178K	Buy	1,936 +776	+67%	+$82K	﹤0.01%	1285
2024 Q4	$131K	Buy	1,160 +8	+0.7%	+$926	﹤0.01%	978
2024 Q3	$125K	Buy	1,152 +15	+1%	+$1.65K	﹤0.01%	897
2024 Q2	$131K	Buy	1,137 +54	+5%	+$6.21K	0.01%	803
2024 Q1	$132K	Sell	1,083 -25	-2%	-$2.79K	0.01%	791
2023 Q4	$119K	Sell	1,108 -44	-4%	-$4.38K	0.01%	789
2023 Q3	$121K	Buy	1,152 +44	+4%	+$4.96K	0.01%	819
2023 Q2	$124K	Hold	1,108	–	–	0.01%	817
2023 Q1	$125K	Sell	1,108 -42,541	-97%	-$4.86M	0.01%	776
2022 Q4	$4.76M	Buy	43,649 +13,549	+45%	+$1.53M	0.29%	97
2022 Q3	$3.16M	Sell	30,100 -262	-0.9%	-$31.3K	0.22%	113
2022 Q2	$3.5M	Buy	30,362 +2,064	+7%	+$262K	0.17%	134
2022 Q1	$4.28M	Buy	28,298 +25,540	+926%	+$3.94M	0.18%	133
2021 Q4	$542K	Sell	2,758 -296	-10%	-$60.1K	0.02%	555
2021 Q3	$606K	Sell	3,054 -3	-0.1%	-$632	0.02%	522
2021 Q2	$622K	Sell	3,057 -169	-5%	-$31.6K	0.02%	505
2021 Q1	$578K	Hold	3,226	–	–	0.02%	600
2020 Q4	$544K	Sell	3,226 -31,647	-91%	-$4.53M	0.02%	517
2020 Q3	$4.37M	Buy	34,873 +3,225	+10%	+$426K	0.23%	104
2020 Q2	$3.76M	Buy	31,648 +8,057	+34%	+$919K	0.21%	113
2020 Q1	$2.32M	Sell	23,591 -370	-2%	-$45.3K	0.16%	148
2019 Q4	$2.94M	Buy	23,961 +2,240	+10%	+$264K	0.16%	159
2019 Q3	$2.46M	Buy	21,721 +1,587	+8%	+$177K	0.15%	161
2019 Q2	$2.21M	Buy	20,134 +661	+3%	+$69.5K	0.14%	163
2019 Q1	$1.95M	Sell	19,473 -1,485	-7%	-$143K	0.13%	181
2018 Q4	$1.94M	Buy	20,958 +361	+2%	+$35K	0.14%	168
2018 Q3	$2.25M	Buy	20,597 +1,858	+10%	+$215K	0.15%	163
2018 Q2	$2.18M	Buy	18,739 +1,741	+10%	+$202K	0.17%	138
2018 Q1	$1.83M	Buy	16,998 +346	+2%	+$38.5K	0.16%	133
2017 Q4	$1.75M	Buy	16,652 +767	+5%	+$74.8K	0.16%	146
2017 Q3	$1.44M	Buy	15,885 +1,453	+10%	+$120K	0.14%	150
2017 Q2	$1.07M	Buy	14,432 +5,219	+57%	+$373K	0.11%	177
2017 Q1	$641K	Sell	9,213 -30,470	-77%	-$2.16M	0.07%	228
2016 Q4	$2.99M	Buy	39,683 +11,165	+39%	+$791K	0.39%	70
2016 Q3	$1.9M	Buy	28,518 +23,454	+463%	+$1.63M	0.26%	96
2016 Q2	$366K	Sell	5,064 -881	-15%	-$65.6K	0.05%	308
2016 Q1	$439K	Buy	+5,945	New	+$413K	0.07%	256

Other funds holding TROW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's TROW Position: Q1 2026 in Review

Geneos Wealth Management increased its T. Rowe Price (TROW) stake by 56% in Q1 2026, buying an estimated $32.8K and bringing the position to 945 shares worth $85.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

Geneos Wealth Management first reported a position in TROW in Q1 2016 and has held it in 41 quarters since. The position peaked at $4.76M in Q4 2022. 1,087 funds tracked by Wall St. Rank hold TROW as of Q1 2026.

Geneos Wealth Management held 945 shares of T. Rowe Price worth $85.2K as of Q1 2026.
Geneos Wealth Management bought 339 T. Rowe Price shares in Q1 2026, an estimated $32.8K.
T. Rowe Price made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1225 holding.
Geneos Wealth Management first reported a position in T. Rowe Price in Q1 2016 and has held it in 41 quarters since.
Geneos Wealth Management's T. Rowe Price position peaked at $4.76M in Q4 2022.
1,087 funds tracked by Wall St. Rank held T. Rowe Price as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.